How rapid palatal expansion remodels the upper airway in three dimensions—and what your CBCT imaging should show.
TL;DR Rapid palatal expansion (RPE) produces measurable three-dimensional airway changes in growing patients, particularly enlargement of the nasal cavity and pyriform aperture. CBCT imaging reveals significant increases in transverse airway dimensions, with sustained improvements when proper consolidation protocols are followed.
Three-dimensional airway changes after rapid palatal expansion represent a critical intersection of skeletal expansion and respiratory physiology in the growing patient. In this article, Dr. Mark Radzhabov examines the CBCT findings documented in pediatric RPE cases—including nasal cavity expansion, pyriform aperture widening, and nasopharyngeal volume changes—drawing on clinical practice and peer-reviewed evidence to provide a practical framework for case selection and outcome assessment.
Rapid palatal expansion operates on the principle that midpalatal suture separation initiates a cascade of skeletal and soft tissue adaptations. In growing patients, the immature suture permits rapid transverse widening—typically 4 to 5 mm of maxillary expansion over 10 to 20 activation days. However, the airway effects extend well beyond horizontal jaw widening.
The nasal cavity, which shares anatomical continuity with the palate via the vomer and perpendicular plate of the ethmoid, undergoes concurrent three-dimensional remodeling. Cone-beam computed tomography (CBCT) imaging reveals that transverse expansion of the hard palate correlates with simultaneous widening of the nasal floor, elevation of the nasal vault, and anterior displacement of the soft palate. These changes collectively increase airway volume in the coronal, sagittal, and axial planes.
The magnitude of airway expansion varies based on several factors: baseline skeletal maturity (more pronounced in pre-adolescent versus adolescent patients), initial severity of maxillary constriction, suture morphology, and consolidation duration. Studies using three-dimensional airway assessment methods have documented mean increases in nasal cavity cross-sectional area ranging from 15 to 35 percent, with the greatest gains occurring in the anterior and middle nasal passages.
Understanding these three-dimensional changes is essential for informed patient selection and outcome prediction. Clinicians must recognize that RPE is not merely a dental procedure but a skeletal intervention with measurable effects on the entire upper airway anatomy.
Cone-beam computed tomography has become the gold standard for documenting post-RPE airway changes because it provides true three-dimensional reconstruction without the superimposition artifacts inherent in conventional radiography. CBCT analysis captures cross-sectional area measurements, volumetric calculations, and anteroposterior depth changes—data essential for assessing treatment efficacy.
In pediatric patients undergoing RPE, CBCT studies consistently demonstrate widening of the nasal cavity floor (the horizontal dimension between the lateral nasal walls). The pyriform aperture—the anterior bony opening of the nasal cavity—shows measurable anterior displacement and lateral expansion. These changes reflect the mechanical consequence of palatal shelf widening, as the palate and nasal floor are continuous structures separated only by soft tissue mucosa.
The nasopharyngeal cross-section, measured at the level of the soft palate, also expands following RPE. This expansion is clinically significant because nasopharyngeal narrowing is a recognized contributor to obstructive breathing patterns in growing patients. By widening this space, RPE reduces the likelihood of soft palate collapse during inspiration and improves overall respiratory tract patency.
CBCT measurement protocols vary across research centers, but the most reliable methods employ standardized anatomical landmarks: the anterior nasal spine, posterior nasal spine, and the most lateral points of the nasal wall at the level of the turbinates. Clinicians performing CBCT scans should insist on high-resolution reconstructions in the coronal, sagittal, and axial planes to enable accurate three-dimensional airway assessment.
Effective use of CBCT for RPE airway assessment requires a structured protocol. Baseline CBCT imaging should be obtained prior to appliance placement in patients with suspected airway compromise or severe maxillary constriction. This baseline scan serves multiple purposes: it documents initial nasal anatomy, identifies anatomical variants (septal deviation, turbinate hypertrophy), and provides a reference for post-treatment comparison.
Active RPE phase typically lasts 10 to 20 days (one quarter-turn per day or one full turn every four days, depending on appliance type and clinical goals). During this active phase, clinical assessment focuses on suture separation visibility, dental midline correction, and patient tolerance. A repeat CBCT scan at the conclusion of the active phase is optional but valuable for documenting immediate expansion magnitude and ruling out root resorption or alveolar bone loss.
The consolidation phase—lasting 6 to 12 months—is critical for skeletal stabilization and long-term airway benefit. A final CBCT scan 3 to 6 months post-activation captures the remodeled airway anatomy after bone maturation and soft tissue adaptation are complete. This timing permits meaningful assessment of sustained airway improvement without the confounding variable of residual remodeling. Comparison of pre- and post-treatment CBCT scans using volumetric or cross-sectional analysis tools provides objective evidence of treatment efficacy for documentation and patient communication.
For miniscrew-assisted rapid palatal expansion (MARPE) cases in growing patients, the same CBCT protocol applies, though clinicians must account for miniscrew artifacts when measuring airway dimensions in the immediate area of screw placement. Using orthogonal reformatting and avoiding the artifact zone ensures accurate measurements.
The clinical question orthodontists frequently ask is whether three-dimensional airway expansion translates into functional respiratory improvement. Evidence suggests that RPE produces measurable gains in nasal airflow and oxygen saturation in selected populations, though outcomes vary based on etiology and baseline severity.
In pediatric patients with maxillary constriction and concurrent sleep-disordered breathing, published reports document significant reductions in apnea-hypopnea index (AHI) following RPE. One landmark study in children with obstructive sleep apnea syndrome showed that following RPE, mean AHI decreased from 12.2 events per hour to below 1 event per hour, accompanied by normalization of anterior rhinometric measurements. However, systematic reviews of the broader literature reveal considerable heterogeneity in outcomes, with some studies showing robust improvements and others demonstrating minimal change in polysomnographic parameters.
This variability reflects the multifactorial nature of pediatric obstructive sleep apnea. OSA is not solely a consequence of maxillary constriction; adenotonsillar hypertrophy, nasal septal deviation, tongue base positioning, and neuromuscular factors all contribute. RPE is therefore most effective in patients whose airway obstruction phenotype is primarily attributable to transverse maxillary deficiency. Careful patient selection—including clinical evaluation for adenotonsillar size, nasal obstruction history, and polysomnographic confirmation of sleep-disordered breathing—maximizes the likelihood of clinically meaningful respiratory improvement.
Functional outcomes beyond sleep parameters also warrant assessment. Parents often report improvements in daytime nasal breathing, reduced mouth breathing, better sleep quality, and improved behavioral attention following successful RPE. These qualitative outcomes, combined with objective CBCT evidence of airway expansion, provide compelling justification for the procedure in appropriately selected growing patients.
The literature on RPE-induced airway changes presents a nuanced picture. While anatomical studies consistently document transverse expansion of the nasal cavity and pyriform aperture, functional respiratory outcomes show greater variability. Systematic reviews indicate that RPE studies in pediatric obstructive sleep apnea are based predominantly on low-quality evidence, with significant heterogeneity in patient age, follow-up duration, outcome measurement protocols, and baseline severity.
This evidence landscape should inform clinical expectations. RPE reliably produces three-dimensional airway expansion in skeletal terms—CBCT evidence is clear on this point. However, the translation of anatomical expansion into complete resolution of obstructive breathing cannot be guaranteed in all patients. Management decisions should be individualized and phenotype-driven: patients with isolated maxillary transverse deficiency and mild to moderate sleep-disordered breathing represent the most favorable candidate pool.
Conversely, patients with significant adenotonsillar hypertrophy, septal deviation, or severe sleep apnea phenotypes requiring polysomnographic diagnosis should be evaluated in collaboration with otolaryngology and sleep medicine before RPE is undertaken as a primary intervention. In such cases, RPE may be a valuable adjunctive treatment following medical optimization (e.g., adenotonsillectomy), but it should not be positioned as a standalone cure.
Clinicians should also recognize that long-term stability of airway improvements depends on proper consolidation protocol, continued orthodontic development in the context of normal growth, and absence of relapse. Documentation via CBCT at strategic time points—baseline, post-active phase, and 3–6 months post-activation—provides objective evidence for patient communication and supports evidence-based treatment justification to third-party payers.
Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.
Essentials of rapid palatal expansion for practicing orthodontists.
Deep-dive into MARPE protocol, diagnostics, and clinical execution.
5-element medical consultation framework for dentists and orthodontists.
CBCT reveals transverse widening of the nasal cavity floor, anterior displacement and lateral expansion of the pyriform aperture, elevation of the nasal vault, and increased nasopharyngeal cross-sectional area. Mean nasal cavity enlargement ranges from 15–35 percent.
The nasal floor and hard palate are continuous skeletal structures separated only by mucosa. Palatal transverse expansion mechanically widens the nasal floor via the vomer and perpendicular plate of the ethmoid, simultaneously enlarging the nasal cavity.
Final CBCT imaging should occur 3–6 months post-activation to allow complete bone maturation and soft tissue adaptation, ensuring that measured airway expansion reflects stabilized anatomy rather than residual remodeling.
RPE produces consistent anatomical airway expansion, but functional improvement varies. Best outcomes occur in patients with isolated maxillary transverse deficiency and mild-to-moderate OSA. Severe OSA, adenotonsillar hypertrophy, or septal deviation often require concurrent medical or surgical intervention.
Use standardized anatomical landmarks: anterior nasal spine, posterior nasal spine, and the most lateral points of the nasal wall at turbinate level. Orthogonal reformatting in coronal, sagittal, and axial planes ensures reproducible volumetric and cross-sectional measurements.
RPE reliably expands nasal dimensions (CBCT evidence is clear), but functional respiratory improvement depends on baseline phenotype and concurrent airway contributors (adenotonsillar size, septal deviation). Patient selection is critical for predicting functional success.
Yes, the skeletal mechanism is identical in growing patients: midpalatal suture separation drives transverse maxillary and nasal expansion. MARPE may offer biomechanical advantages in non-growing patients but produces equivalent airway remodeling in the growing skeleton.
Anterior rhinometry quantifies nasal airflow resistance objectively. Combined with CBCT volumetric data and clinical breathing assessment, it provides multi-modal evidence of treatment efficacy and helps differentiate anatomical expansion from functional improvement.
Evidence supports 6–12 months of consolidation (retention with the device in place or use of a fixed appliance) to allow complete bone maturation and prevent relapse. Shorter consolidation periods risk incomplete stabilization of expanded airway dimensions.
Baseline CBCT pre-treatment (document initial anatomy), optional mid-treatment CBCT at end of active phase (assess immediate expansion and root health), and final CBCT 3–6 months post-activation (objective measurement of sustained airway improvement and skeletal outcome).
CBCT assessment of airway dimensions should become a routine component of RPE treatment planning and outcome documentation in growing patients, particularly those with coexisting breathing concerns. Dr. Mark Radzhabov recommends reviewing your current imaging protocol and considering a consultation or case review to evaluate whether your patients are capturing the full three-dimensional benefit of skeletal expansion therapy.